Arca
Skip to content

Ureteral Stent Systems, Biliary Drainage Catheters

Stent, Ureteral. 510(k) K191446, from Boston Scientific Corporation (Marborough, MA). Product code FAD, class 2.

As of Nov 17, 2026, K191446 is an FDA 510(k) held by Boston Scientific Corporation, substantially equivalent on Jan 2, 2020 after 216 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Jan 2, 2020
  • Review time: 216 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The Flexima™ Ureteral Stent System and Flexima™ Ureteral Stent System Kit is intended to provide drainage from the ureteropelvic junction to the bladder and stenting of the ureter for all patients in whom it is desirable to place a drain which does not extend externally.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other FAD Clearances

The newest 510(k)s for the same product code; their median review was 185 days; see every FAD device

Record

Type
Traditional
Received
May 31, 2019
Review panel
Gastroenterology, Urology
Regulation
21 CFR 876.4620

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.